865233-82-5

Basic information

• Product Name: 2,2-Dimethyl-5-[4-(tetrahydro-pyran-2-yloxy)-benzylidene]-[1,3]dioxane-4,6-dione
• Synonyms: 2,2-Dimethyl-5-[4-(tetrahydro-pyran-2-yloxy)-benzylidene]-[1,3]dioxane-4,6-dione
• CAS NO: 865233-82-5
• Molecular Weight: 332.353
• Mol File: 865233-82-5.mol

Chemical Properties

• CAS DataBase Reference: 2,2-Dimethyl-5-[4-(tetrahydro-pyran-2-yloxy)-benzylidene]-[1,3]dioxane-4,6-dione(CAS DataBase Reference)
• NIST Chemistry Reference: 2,2-Dimethyl-5-[4-(tetrahydro-pyran-2-yloxy)-benzylidene]-[1,3]dioxane-4,6-dione(865233-82-5)
• EPA Substance Registry System: 2,2-Dimethyl-5-[4-(tetrahydro-pyran-2-yloxy)-benzylidene]-[1,3]dioxane-4,6-dione(865233-82-5)

Safety Data

• Hazardous Substances Data: 865233-82-5(Hazardous Substances Data)

Upstream product

• 110-87-2 3,4-dihydro-2H-pyran 
• 17474-27-0 5-(4-hydroxy-benzylidene)-2,2-dimethyl-[1,3]dioxane-4,6-dione 
• 2033-24-1 cycl-isopropylidene malonate 

Downstream Products

• 1073545-69-3 ethyl (3S)-3-(4-(((6-(1,1-dimethylethyl)-2'-fluoro-5'-(methyloxy)-1,1'-biphenyl-3-yl)methyl)oxy)phenyl)-4-methyl-4-pentenoate 
• 1073545-65-9 ethyl (3R)-3-(4-(((6-(1,1-dimethylethyl)-2'-fluoro-5'-(methyloxy)-1,1'-biphenyl-3-yl)methyl)oxy)phenyl)-4-methyl-4-pentenoate 
• 1073543-90-4 (3S)-3-(4-(((6-(1,1-dimethylethyl)-2'-fluoro-5'-(methyloxy)-1,1'-biphenyl-3-yl)methyl)oxy)phenyl)-4-methyl-4-pentenoic acid 
• 1073543-86-8 (3R)-3-(4-(((6-(1,1-dimethylethyl)-2'-fluoro-5'-(methyloxy)-1,1'-biphenyl-3-yl)methyl)oxy)phenyl)-4-methyl-4-pentenoic acid 
• 1073546-69-6 ethyl (3S)-3-(4-(((6-(1,1-dimethylethyl)-2'-fluoro-5'-(methyloxy)-1,1'-biphenyl-3-yl)methyl)oxy)phenyl)butanoate 
• 1073546-75-4 ethyl (3R)-3-(4-(((6-(1,1-dimethylethyl)-2'-fluoro-5'-(methyloxy)-1,1'-biphenyl-3-yl)methyl)oxy)phenyl)butanoate 
• 1073544-29-2 (3S)-3-(4-(((6-(1,1-dimethylethyl)-2'-fluoro-5'-(methyloxy)-1,1'-biphenyl-3-yl)methyl)oxy)phenyl)butanoic acid 
• 1073544-31-6 (3R)-3-(4-(((6-(1,1-dimethylethyl)-2'-fluoro-5'-(methyloxy)-1,1'-biphenyl-3-yl)methyl)oxy)phenyl)butanoic acid 
• 1073545-61-5 ethyl (3R)-(4-hydroxyphenyl)-4-methyl-4-pentenoate 
• 1073545-63-7 ethyl (3S)-(4-hydroxyphenyl)-4-methyl-4-pentenoate 
• 1073545-59-1 ethyl 3-(4-hydroxyphenyl)-4-methyl-4-pentenoate 
• 1073546-73-2 (R)-ethyl 3-(4-hydroxyphenyl)butanoate 
• 1073546-71-0 (S)-ethyl 3-(4-hydroxyphenyl)butanoate 
• 1073545-57-9 ethyl 4-methyl-3-(4-(tetrahydro-2H-pyran-2-yloxy)phenyl)-4-pentenoate 

Relevant articles and documents

Development of a scalable synthesis of a GPR40 receptor agonist

Early process development and salt selection for AMG 837, a novel GPR40 receptor agonist, is described. The synthetic route to AMG 837 involved the convergent synthesis and coupling of two key fragments, (S)-3-(4-hydroxyphenyl) hex-4-ynoic acid (1) and 3-

Conformationally constrained 3-(4-hydroxy-phenyl)-substituted-propanoic acids useful for treating metabolic disorders

The present invention provides compounds useful, for example, for treating metabolic disorders in a subject. Such compounds have the general formula I: where the definitions of the variables Q, L1, L2, M, X, L3, and A are provided herein. The present invention also provides compositions that include, and methods for using, the compounds in preparing medicaments and for treating metabolic disorders such as, for example, type II diabetes.

Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders

The present invention provides compounds useful, for example, for modulating insulin levels in a subject and that have the general formula [in-line-formulae]Q-L1-P-L2-M-X-L3-A [/in-line-formulae] wherein the definitions of